Is there a need to identify novel tumour antigens as targets for immunotherapy clinical trials for the removal of minimal residual disease in haematological malignancies?
- Barbara Guinn
Research Output: Contribution to journal Article Peer-review
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Publication Information
Output type
Research Output: Contribution to journal Article Peer-review
Original language
EnglishPages from-to (Number of pages)
Pages 24-26Journal (Volume, Issue Number)
International journal of hematology research (Volume 1)Publication milestones
- Published - 01/07/2015
Publication status
Published - 01/07/2015
External Publication IDs
- handle.net: 10547/578850
